The Influx Healthtech IPO is scheduled to open for subscription on Wednesday, June 18, 2025, and will close on Friday, June 20, 2025. The allotment is expected to be finalized on Monday, June 23, 2025, with refunds initiated on Tuesday, June 24, 2025. Shares will be credited to Demat accounts on the same day, and the IPO is tentatively set to be listed on NSE SME on Wednesday, June 25, 2025. Retail investors should confirm their UPI mandate by 5 PM on June 20, 2025 to ensure successful application.
Influx Healthtech IPO is a book-built issue of ₹58.57 crores, which includes a fresh issue of ₹48.00 crores and an offer for sale (OFS) of 11,00,400 equity shares, aggregating to ₹10.56 crores. The face value of each share is ₹10. The price band for the IPO is set at ₹91 to ₹96 per share.
The company has shown steady growth in its financials. In FY 2025, it reported revenue of ₹104.99 crores and a profit of ₹13.37 crores, compared to revenue of ₹100.10 crores and a profit of ₹11.22 crores in FY 2024. Based on this performance, long-term investors may consider subscribing to the IPO.
The IPO allocation is divided as follows: 50% to Qualified Institutional Buyers (QIBs), 35% to Retail Investors, and 15% to High Net-Worth Individuals (HNIs). The minimum lot size is 1,200 shares, which requires a retail investment of ₹1,09,200 at the lower end of the price band. However, to increase the chance of allotment in case of oversubscription, bidding at the cutoff price (₹96) is advised, bringing the investment to ₹1,15,200. HNI investors need to apply for at least 2 lots (2,400 shares), amounting to ₹2,30,400.
Overview of Contents
About Influx Healthtech IPO
Influx Healthtech Limited, started in 2020, is a fast-growing healthcare company that focuses on contract manufacturing. It is known as a trusted CDMO (Contract Development and Manufacturing Organization), helping many well-known brands by providing full support in product development, manufacturing, and regulatory compliance. The company operates three well-equipped manufacturing units in Thane, Maharashtra, spread across areas of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. These facilities are designed to maintain high standards of safety, quality, and legal compliance.
Influx Healthtech offers a wide product range, including nutritional supplements, ayurvedic and herbal products, cosmetics, veterinary feed supplements, and homecare items. Some of their popular products are tablets, capsules, powders, liquids, softgels, jellies, gummies, ODFs (Oral Dispersible Films), effervescent tablets, skincare and haircare solutions, face masks, soaps, and sports/gym supplements.
The company works with many reputed clients like Bling Brands, BigFlex Lifescience, Novus Life Science, Fredun Pharmaceuticals, Aarkios Health, Bruder Life Science, and others. As of June 2025, the company has 163 permanent employees.
The biggest strengths of Influx Healthtech are its diverse product portfolio, wide client base, strong quality control practices, and experienced promoters and management team. These factors make Influx Healthtech a strong player in the healthcare manufacturing sector, and a promising company for long-term investors.
Influx Healthtech IPO Overview
| IPO Details | Information |
|---|---|
| Listing Exchange | NSE SME |
| IPO Type | Book Built Issue |
| Price Band | ₹91 to ₹96 per share |
| Face Value per Share | ₹10 |
| Market Lot Size | 1,200 shares |
| Total Shares Offered | 61,00,800 shares |
| Total Issue Size | Approx ₹58.57 Crores |
| Fresh Issue Size | 50,00,400 shares (Approx ₹48.00 Cr) |
| Offer for Sale (OFS) | 11,00,400 shares (Approx ₹10.56 Cr) |
| Pre-Issue Equity Shares | 1,81,50,000 shares |
| Post-Issue Equity Shares | 2,31,50,400 shares |
| Allocation to QIBs | Not more than 50% |
| Allocation to Retail Investors | Not more than 35% |
| Allocation to HNIs (NII) | Not more than 15% |
| Market Maker Reservation | 3,06,000 shares |
| Draft Prospectus (DRHP) | Filed with IPO timeline: June 18–20, 2025 |
Influx Healthtech IPO Prospectus
| DRHP | Click here |
| RHP | Click here |
Influx Healthtech IPO Dates
| Event | Date (Day) |
|---|---|
| IPO Open Date | June 18, 2025 (Wednesday) |
| IPO Close Date | June 20, 2025 (Friday) |
| Basis of Allotment | June 23, 2025 (Monday) |
| Refunds Initiation | June 24, 2025 (Tuesday) |
| Credit to Demat Account | June 24, 2025 (Tuesday) |
| IPO Listing Date | June 25, 2025 (Wednesday) |
Influx Healthtech IPO Lot Size
Retail and HNI investors can apply for the Influx Healthtech IPO in a minimum lot size of 1,200 shares and in multiples thereafter. Below is a quick view of the minimum and maximum investment limits:
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,15,200 |
| Retail (Max) | 1 | 1,200 | ₹1,15,200 |
| HNI (Min) | 2 | 2,400 | ₹2,30,400 |
Influx Healthtech IPO Promoter Holding
The promoters of Influx Healthtech Limited are Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala, and Mr. Abdul Ganee Abdul Rasul Chandniwala. They have maintained strong control over the company both before and after the IPO.
| Shareholding | Percentage |
| Pre-Issue Holding | 99.85% |
| Post-Issue Holding | 73.53% |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Sudarshan Pharma Industries Limited | 0.66 | 48.28 | 12.45% | 5.30 | 505.38 Cr. |
| Quest Laboratories Limited | 8.28 | 10.38 | 16.58% | 49.92 | 108.16 Cr. |
Influx Healthtech IPO Financial Performance
Influx Healthtech has shown consistent growth over the last three financial years. The company’s revenue increased by 5% and profit after tax (PAT) rose by 19% from FY 2024 to FY 2025, reflecting strong financial performance.
| Financial Metrics (₹ in Crores) | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 70.30 | 41.10 | 28.30 |
| Revenue | 104.99 | 100.10 | 76.07 |
| Profit After Tax (PAT) | 13.37 | 11.22 | 7.20 |
| Net Worth | 36.15 | 22.87 | 11.65 |
| Reserves and Surplus | 18.00 | 22.85 | 11.63 |
| Total Borrowing | 0.22 | 0.32 | 0.80 |
Influx Healthtech IPO Valuation Highlights – FY2025
Influx Healthtech shows strong financial health with impressive return ratios and low debt. The company has a high RoNW of 36.98%, a solid EBITDA margin of 19.62%, and a nearly negligible debt-to-equity ratio of 0.01, reflecting financial stability and operational efficiency.
| Key Financial Indicator | Value (FY2025) |
|---|---|
| Return on Equity (ROE) | 36.98% |
| Return on Capital Employed (ROCE) | 49.17% |
| EBITDA Margin | 19.62% |
| Profit After Tax (PAT) Margin | 12.75% |
| Debt-to-Equity Ratio | 0.01 |
| Earnings Per Share (EPS) | ₹7.36 (Basic) |
| Price-to-Earnings (P/E) Ratio | N/A |
| Return on Net Worth (RoNW) | 36.98% |
| Net Asset Value (NAV) | ₹19.91 |
Object of the issue
- Set up a new manufacturing unit for the Nutraceutical division
- Establish a facility for the Veterinary feed supplements division
- Purchase machinery for Homecare and Cosmetic divisions
- Use funds for general corporate purposes
Influx Healthtech IPO Review
- Geojit –
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Swastika Investmart –
- Ventura Securities –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking –
🧾 IPO Registrar
📍 Name: Maashitla Securities Private Limited
📞 Phone: +91-11-45121795-96
📧 Email: [email protected]
🌐 Website: maashitla.com/allotment-status/public-issues
🏦 IPO Lead Manager (Merchant Banker)
💼 Company: Rarever Financial Advisors Pvt. Ltd.
🏢 Company Address
Influx Healthtech Limited
📍 109, Ghanshyam Enclave Premises Co-op Soc, Plot No. 856, Laljipada,
Kandivali West, Mumbai, Maharashtra
📞 Phone: +91 7045997809
📧 Email: [email protected]
🌐 Website: influxhealthtech.com
Influx Healthtech IPO FAQs
When will the Influx Healthtech IPO open and close?
The Influx Healthtech IPO will open on June 18, 2025 (Wednesday) and close on June 20, 2025 (Friday).
What is the price band and minimum investment for retail investors?
The IPO price band is ₹91 to ₹96 per share. The minimum lot size is 1,200 shares, requiring an investment of ₹1,15,200 for retail investors.
What is the total issue size of the IPO?
The total issue size is approximately ₹58.57 crores, including a fresh issue of ₹48 crores and an offer for sale of 11,00,400 shares.
When is the Influx Healthtech IPO listing date?
The shares are expected to be listed on the NSE SME platform on June 25, 2025 (Wednesday).
What will the company use the IPO funds for?
The funds will be used for:
- Setting up manufacturing units for Nutraceutical and Veterinary divisions
- Purchasing machinery for Homecare and Cosmetic units
- Meeting general corporate expenses